Generic Pharmaceuticals Company Investment Opportunity in Hyderabad, India

Pharmaceutical start-up company developing potentially "super generic" versions of omeprazole, aspirin and naproxen.
This Business is on a Premium Plan
Established From
Employees
Legal Entity
Reported Sales
Run Rate Sales
Nil
EBITDA Margin
Operating at break even
Locations
Local Time
7:34 AM Hyderabad
Listed By
Business Owner / Director
Status
Active
Overall Rating
Seeking Investment
USD 630 thousand for 20.0% stake (Native Currency: INR 44,000,000)
Reason: Our immediate objective is to develop a potential super generic omeprazole through 505 (b) (2) NDA r... View More
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview

- We are a generic pharmaceutical R&D company that is based in Hyderabad, India.

- Developing 3 NCEs that are potential "super generic" versions of widely-used drugs - omeprazole, naproxen and aspirin.

- USA and Canada are our primary markets and we will also bring our products to India once they gain respectable sales figures.

- Planning to develop these NCEs through the least-expensive 505 (b) (2) NDA route, which is the most economical and fastest route to drug development and approval by the US FDA.

- Currently in the pre-clinical stage and will get all the regulatory approvals as per the requirement.

- We have already obtained a US patent for 2 NCEs (i. e. , Super generic versions of naproxen and aspirin) and we are in the process of filing a patent application for the other NCE (i. e. , a potential super generic omeprazole).

- With an initial investment of Rs. 4.4 Crores (~600,000 USD), we will take up omeprazole prodrug as our first candidate for development through 505 (b) (2) NDA route.

- Once we reach the manufacturing stage, we may outsource all the manufacturing of these products.

Products & Services Overview

We intend to develop potentially "super generic" versions of widely used generic drugs omeprazole, naproxen and aspirin.

Facilities Overview
Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

Frequently
Asked
Questions

  • Why can’t I see the business’ name or contact number? How do I contact the business?
  • What level of due diligence does SMERGERS conduct on the businesses/member?
  • How can I be sure that the business profile will be active?
  • How does SMERGERS rate business profiles?
  • Do I need to pay to connect with a business?
  • Show more